Claritev (MultiPlan) Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
We'll go ahead and get started. I'm Richard Close with Canaccord Genuity, covering digital and tech-enabled health. We're excited to have Claritev with us today. I think it's a really interesting story. From the company, we have Doug Garis, CFO, with us here today. Company's made meaningful progress under its Vision 2030 strategy, and the third quarter definitely provided further evidence of the strategy gaining traction. We'll dive into the third quarter a little bit deeper, but for investors newer to the story, Doug, let's just begin by just level setting, letting us know what Claritev does and what value the company's bringing to healthcare.
Sure. Thank you, Richard, and thanks to Canaccord. We've had a great conference so far. For those new to the Claritev story, Claritev has primarily three businesses. Our largest business focuses on out-of-network spend. Within the U.S. healthcare system, which is a little over $5 trillion in total spend, about 7% or 8% of that spend goes out of network for a variety of reasons. We serve as a cost containment affordability solution when a person goes out of network for various reasons. That's our largest business. We then actually have the largest independent PPO in the country, where we rent our network to large insurance carriers and TPAs, and we have 1.4 million providers under contract. That's a really strategic business. It's actually how Claritev was founded. It was founded as a network company.
Finally, we process over 5.5 billion claims a year through our payment and revenue integrity business, and that business really focuses on catching boo-boos on claims before they get submitted for payment. We also do a whole host of post-payment, payment revenue integrity, things like payment accuracy, coordination of benefits, and subrogation. When you look at those three businesses in total, that is what Claritev does, and does pretty successfully.
When I look at healthcare and everything that drove the recent election, affordability and healthcare affordability specifically is right up there. Everyone complains, "I don't know what prices are in healthcare." Talk a little bit about what your products do to address affordability issues and transparency issues.
Yeah. We actually just released a new solution called transparency-based pricing, which we are really excited about. Transparency is the law of the land. Payers and providers must submit transparency files. They are called MRF, machine-readable files. We process over 500 billion records a month and cleanse the data based on the transparency laws and regulations. When you really step back and think about the out-of-network business, what we do is we use a whole myriad of publicly available data to serve up an insight for a health insurance carrier operating on the behalf of an employer and ultimately the consumer to make sure whenever you go out of network or see a provider that is not within your health insurance network, primarily for self-insured companies, we prevent kind of the astronomical charges from happening. It is the simplest way to think about it.
We always kind of joke around and use the example of a $20,000 splinter. That is funny, not funny, because in our claims data, that has actually happened before. We are having a great time at a conference, you get a splinter, you go to a doctor, you get a $20,000 bill. Really, when you think about our out-of-network business and our cost containment business, that is what we mean when we talk about affordability. From a transparency perspective, we think over the next several years, transparency is going to become increasingly important because, as you mentioned, we are staring at 15-year highs of healthcare inflation. Pretty much all the various kind of macro indicators are suggesting that healthcare inflation is going to increase double digits next year.
For most consumers who buy their health insurance through their employer, that means your monthly premiums are going up 10%. We really like the position that we are in from an affordability perspective. As we develop solutions and bring them to the market for the future, we are really focused on transparency, and transparency is the law of the land. We think it is a really important thing to focus on for consumers of healthcare.
Okay. Out-of-network, in the claims intelligence business, you have concentration with customers. I mean, obviously, the largest of the large are your customers. Can you talk about what you are doing about that concentration? You have made some progress over the last several years, for sure.
Sure. But just talk about that, what the risks are associated with that client base.
Yeah. We just eclipsed $1 billion of last 12-month revenue as the end of Q3. To get to the size of $1 billion of revenue and north of $600 million of EBITDA, you need big clients, right? Not surprisingly, our 10 largest customers are the familiar names within the book, so large national payers. What we've done over the last two years under our CEO and President Travis Dalton's leadership is we've brought in a refreshed management team. We've hired a chief growth officer. We've aligned our go-to-market strategy around our market verticals, which historically have been the payer and the TPA or third-party administrator space. We like having large clients. If you look at our $100 million of bookings year to date, 78% of that's come from our current install base.
A mix of refreshed sales leadership team, select investments in sales and marketing, and then our core fundamental thesis is, we can sell our solutions into multiple markets. Within that bookings number year to date, more than 50% of our bookings have come from outside of our core payer segment, which is our largest segment. We've started doing business with providers, so we signed a top five health system here at the beginning of the year. We started doing business with state and local and federal government and agencies. We had announced earlier this year that we are the primary network for the World Trade Center first responders and survivors with respiratory issues. That's a national network. We've opened into international markets.
We like some of the medium and long-term prospects as emerging nations are experiencing a lot of the similar issues with healthcare inflation, and then we've opened a broker and employer space. We haven't had to do anything exotic from a product development or innovation standpoint to enter these new markets. We just had to put wood behind the arrow with respect to sales leadership, segment, strategy alignment, and then bag-carrying sales folks who get paid commission when they sell things. There's nothing magical about it. It's just extreme focus on making sure that we can run a diversified go-to-market strategy to overall improve the health of our top-line revenue base.
Okay. Have the changes that you've made with respect to the sales force and targeting the different verticals, is that all done in terms of Or is that still evolving? Do you have to add more people?
Do you have to Yeah, I think it's We announced when we gave our guide this year that we're going to spend about $20 million-$25 million on our go-to-market and delivery functions this year, and we think that was well-timed investment.
Obviously, the midpoint of our bookings indication is $120 million of new bookings growth. If you look at the last two years, that's about $187 million of net incremental ACV bookings under our new system. I think it's reasonable to assume that we're going to continue to invest in our sales, marketing, and go-to-market functions. The great thing is when you run a sales organization at scale, everything you do is on a percentage of revenue, right? You add salespeople, they have quotas, they hit the quotas, you book something, it turns into revenue, and I plan my business on a percentage of revenue basis.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
